Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...
Health-care companies rose slightly amid mixed earnings. CVS Health replaced its top executive as it warned that its coming earnings will once again fall short of Wall Street expectations, sending ...
Bausch + Lomb Corporation (BLCO – Research Report) received a Buy rating and a price target from Evercore ISI analyst Umer Raffat today. The company’s shares closed yesterday at $20.87. According to ...